Published in FASEB J on March 26, 2014
Neutrophil extracellular traps - the dark side of neutrophils. J Clin Invest (2016) 1.19
Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev (2015) 0.99
Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol (2015) 0.86
A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programming. Bioessays (2014) 0.80
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2. Am J Respir Crit Care Med (2016) 0.79
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis. Curr Diab Rep (2016) 0.79
Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus. Nat Med (2016) 0.77
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol (2016) 0.76
B Cell Tolerance to Deiminated Histones in BALB/c, C57BL/6, and Autoimmune-Prone Mouse Strains. Front Immunol (2017) 0.75
Anti-inflammatory interventions-what has worked, not worked, and what may work in the future. Transl Res (2015) 0.75
Transcriptional firing helps to drive NETosis. Sci Rep (2017) 0.75
NETosis as Source of Autoantigens in Rheumatoid Arthritis. Front Immunol (2016) 0.75
Immune recognition of citrullinated epitopes. Immunology (2016) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Neutrophil extracellular traps kill bacteria. Science (2004) 23.64
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (2010) 18.82
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 8.58
Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med (2009) 6.72
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 5.69
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med (2011) 5.60
Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog (2009) 5.40
Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol (2009) 5.27
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 4.74
Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol (2007) 4.65
Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med (2011) 4.51
Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol (2004) 4.41
NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 3.70
Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol (2008) 3.48
Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood (2008) 3.32
Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J Innate Immun (2010) 2.34
Histone H1 and its isoforms: contribution to chromatin structure and function. Gene (2008) 2.32
Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry (2005) 2.21
N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol (2011) 2.18
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One (2012) 2.18
Mapping the interaction surface of linker histone H1(0) with the nucleosome of native chromatin in vivo. Nat Struct Mol Biol (2006) 1.94
Mass spectrometric mapping of linker histone H1 variants reveals multiple acetylations, methylations, and phosphorylation as well as differences between cell culture and tissue. Mol Cell Proteomics (2006) 1.90
Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum (2003) 1.88
Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature (2014) 1.81
Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription. J Biol Chem (2008) 1.66
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest (2013) 1.64
Single-base resolution mapping of H1-nucleosome interactions and 3D organization of the nucleosome. Proc Natl Acad Sci U S A (2010) 1.44
PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One (2011) 1.39
Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum (2010) 1.39
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum (2011) 1.38
PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol (2012) 1.37
Automatic quantification of in vitro NET formation. Front Immunol (2013) 1.35
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med (2008) 1.34
Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. PLoS Genet (2011) 1.33
Activation of PAD4 in NET formation. Front Immunol (2012) 1.30
Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis (2013) 1.29
Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev (2010) 1.19
Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India (2004) 1.14
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood (2010) 1.12
Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol (1995) 1.12
Defensins- and cathepsin G-ANCA in systemic lupus erythematosus. Rheumatol Int (2006) 1.09
Histone H1 phosphorylation is associated with transcription by RNA polymerases I and II. J Cell Biol (2010) 1.08
Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. Surgery (2011) 1.07
Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release. Front Immunol (2013) 1.07
Histone H2A C-terminus regulates chromatin dynamics, remodeling, and histone H1 binding. PLoS Genet (2010) 1.04
Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol (2013) 0.99
Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis (2013) 0.98
Mapping of six somatic linker histone H1 variants in human breast cancer cells uncovers specific features of H1.2. Nucleic Acids Res (2014) 0.93
Pathogenic anti-nucleosome antibodies. Lupus (2008) 0.92
Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int (2001) 0.90
Defensins in systemic lupus erythematosus. Ann N Y Acad Sci (2009) 0.89
Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps. Front Immunol (2012) 0.85
FoxP3 interacts with linker histone H1.5 to modulate gene expression and program Treg cell activity. Genes Immun (2011) 0.85
Nucleosome interaction surface of linker histone H1c is distinct from that of H1(0). J Biol Chem (2010) 0.85
Mapping of linear epitopes of human histone H1 recognized by rabbit anti-H1/H5 antisera and antibodies from autoimmune patients. Mol Immunol (1994) 0.83
Fourier transform infrared/vibrational circular dichroism spectroscopy as an informative tool for the investigation of large supramolecular complexes of biological macromolecules. Biopolymers (2005) 0.81
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model. J Med Chem (2013) 0.80
Epigenetics of autoantigens: new opportunities for therapy of autoimmune diseases. Genet Epigenet (2013) 0.79
Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal (2008) 0.79
Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits. EMBO J (1984) 0.78
Antihistone antibodies in linear scleroderma variants. Int J Dermatol (2006) 0.76